GenomeWeb Index Flat in February; Some Firms See Losses After Q4 Results | GenomeWeb

NEW YORK (GenomeWeb) – The GenomeWeb Index was flat month over month in February, as some stocks seemed to recover from steep losses in January while others fell on fourth quarter results.

The GenomeWeb Index performed roughly in line with the Dow Jones Industrial Average — which gained less than half a percent during the month. But it fared better than the Nasdaq, which fell a little more than 1 percent, and the Nasdaq Biotechnology Index, which finished the month nearly 5 percent lower.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.